Hinrich Bremer

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

F. La Rosée, Hinrich Bremer, Iris Gehrke et al. · Leukemia · 2020 · 243 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Normocapnia during nIPPV in chronic hypercapnic COPD reduces subsequent spontaneous PaCO2

W. Windisch, Michael Vogel, Stephan Sorichter et al. · Respiratory Medicine · 2002 · 94 citations · Full text

Medicine, Clinical Sciences, Respiratory Therapy +13

Compliance in sleep apnoea therapy: influence of home care support and pressure mode

Domagoj Damjanović, A. Fluck, Hinrich Bremer et al. · European Respiratory Journal · 2009 · 79 citations · Full text

Medicine, Respiratory Therapy, Manual Therapy +16

Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin‐8 from human eosinophils

Marco Idzko, Elisabeth Panther, Hinrich Bremer et al. · British Journal of Pharmacology · 2003 · 77 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Exercise Capacity Affects Quality of Life in Patients with Pulmonary Hypertension

Michael Halank, Franziska Einsle, Stephanie S. Lehman et al. · Lung · 2013 · 73 citations

Education, Physiology, Exercise Physiology +13